Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Applied Therapeutics Inc APLT

Healthcare Biotechnology
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare... see more

Recent & Breaking News (NDAQ:APLT)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT

GlobeNewswire August 29, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Applied Therapeutics, Inc. - APLT

GlobeNewswire August 25, 2020

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Applied Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - APLT

GlobeNewswire August 21, 2020

Applied Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

GlobeNewswire August 21, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT

GlobeNewswire August 20, 2020

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors

Business Wire August 20, 2020

The Law Offices of Frank R. Cruz Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors

Business Wire August 20, 2020

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Applied Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Business Wire August 20, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors

Business Wire August 19, 2020

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Applied Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Business Wire August 19, 2020

EQUITY ALERT: ROSEN, A LEADING AND RANKED LAW FIRM, Announces Investigation of Securities Claims Against Applied Therapeutics, Inc. - APLT

Business Wire August 19, 2020

SHAREHOLDER ALERT: Block & Leviton LLP Investigating Applied Therapeutics, Inc. for Possible Securities Laws Violations; Shareholders Should Contact the Firm

GlobeNewswire August 18, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT

PR Newswire August 18, 2020

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Applied Therapeutics, Inc. (APLT) Investigation

ACCESSWIRE IA August 18, 2020

Applied Therapeutics Reports Second Quarter 2020 Financial Results

GlobeNewswire August 11, 2020

Applied Therapeutics to Present Data on AT-007 for Treatment of Galactosemia at the Galactosemia Foundation 2020 Virtual Conference

GlobeNewswire July 17, 2020

Applied Therapeutics Takes Action Against Fraudulent "Short Report"

GlobeNewswire July 6, 2020

Applied Therapeutics Announces Start of AT-007 Pediatric Galactosemia Study; Releases Additional 40mg/kg Data from Adult Galactosemia Study

GlobeNewswire June 15, 2020

Applied Therapeutics to Present Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at 2020 American Diabetes Association Virtual Scientific Sessions

GlobeNewswire June 8, 2020

Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

GlobeNewswire June 3, 2020